Sort
17,288 grants matching “multiple sclerosis”
Translational Immunopsychiatry Unit
$2,309,309Christopher Bartley · National Institute Of Mental Health · ZIA · FY2023 · MH
Ibudilast Phase II trial in progressive MS
$2,308,268Robert J. Fox · Cleveland Clinic Lerner Com-Cwru · U01 · FY2016 · NS
The Impact of Beta- and Gamma-Synucleins on Alpha-Synuclein's Synaptic Function
$2,305,682Jacqueline Burre · Weill Medical Coll Of Cornell Univ · RF1 · FY2022 · NS
Defining the role of altered cytokine signaling pathways on autoimmunity
$2,303,678Jane Hoyt Buckner · Benaroya Research Inst At Virginia Mason · U01 · FY2013 · AI
National Center for Drug Discovery in Neurodegeneration
$2,299,596Gregory D Cuny · Brigham And Women'S Hospital · U24 · FY2009 · NS
Comprehensive multimodal analysis of patients with neuroimmunological diseases
$2,296,246Bibiana Bielekova · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Mouse BIRN
$2,281,799Arthur W Toga · University Of California Los Angeles · U24 · FY2006 · RR
Characterization of the Pathogenesis of Lymphangioleiomyomatosis (LAM)
$2,278,235Joel Moss · National Heart, Lung, And Blood Institute · ZIA · FY2015 · HL
Comprehensive multimodal analysis of patients with neuroimmunological diseases
$2,272,642Bibiana Bielekova · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
Understanding the Persistence of Immune-mediated Chronic Diseases
$2,265,000Vaiva D Vezys · University Of Minnesota · DP2 · FY2009 · OD
Novel commensal polysaccharide treats multiple sclerosis through Treg modulation
$2,264,726Lloyd H Kasper · Symbiotix Biotherapies, Inc. · R42 · FY2015 · AI
Role Of Neuropeptides And Biogenic Amines In Stress and Brain Inflammation
$2,263,494Juan M Saavedra · National Institute Of Mental Health · Z01 · FY2007 · MH
COBRE GRANT
$2,262,935Marwan Noel Sabbagh · Cleveland Clinic Foundation · P20 · FY2019 · GM
SWITCH Trial: Early Feasibility Study of Stentrode BCI for Augmentative Communication
$2,259,253Douglas J Weber · Carnegie-Mellon University · UH3 · FY2022 · NS
Clinical, Imaging, and Pathological Studies in the Oldest Old: The 90+ Study
$2,258,548Claudia H. Kawas · University Of California-Irvine · R01 · FY2021 · AG
GENERAL CLINICAL RESEARCH CENTER
$2,256,532University Of California Los Angeles · M01 · FY2000 · RR
Clinical, Imaging, and Pathological Studies in the Oldest Old: The 90+ Study
$2,253,507Claudia H. Kawas · University Of California-Irvine · R01 · FY2022 · AG
GENERAL CLINICAL RESEARCH CENTER
$2,247,575Scripps Research Institute · M01 · FY2000 · RR
National Center for Drug Discovery in Neurodegeneration
$2,238,265Ross L Stein · Brigham And Women'S Hospital · U24 · FY2008 · NS
Developing therapies to target the microbiota
$2,235,000June Louise Round · University Of Utah · DP2 · FY2014 · AT
COBRE GRANT
$2,230,641Jeffrey L. Cummings · Cleveland Clinic Foundation · P20 · FY2017 · GM
In Vivo Control and Functional Visualization of Stem Cell-Driven CNS Regeneration
$2,209,908Jin Hyung Lee · Stanford University · DP2 · FY2010 · OD
Mechanisms of inherited neurodegenerative diseases
$2,208,322Michael Ward · National Institute Of Neurological Disorders And Stroke · ZIA · FY2024 · NS
B Cells in Health and Disease
$2,204,218Ignacio E. Sanz · Emory University · P01 · FY2012 · AI
Gene Regulation as a Foundation for Autoimmune Disease Prevention
$2,204,137John Barker Harley · Cincinnati Childrens Hosp Med Ctr · U01 · FY2018 · AI